학술논문
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
Document Type
Journal
Author
Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U.; Mandala, Mario; Long, Georgina, V; Atkinson, Victoria G.; Dalle, Stephane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A.; Larkin, James; Lorigan, Paul C.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C. J.; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M. M.; EORTC Melanoma Grp
Source
Subject
Language
English
ISSN
14745488